SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 239 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $958,000 | -10.6% | 33,123 | 0.0% | 0.65% | +6.8% |
| Q1 2022 | $1,071,000 | +16.2% | 33,123 | +4.8% | 0.60% | +21.5% |
| Q4 2021 | $922,000 | +9.4% | 31,618 | 0.0% | 0.50% | +1.0% |
| Q3 2021 | $843,000 | +50.0% | 31,618 | +73.1% | 0.49% | +53.6% |
| Q2 2021 | $562,000 | +20.6% | 18,265 | +2.6% | 0.32% | +13.0% |
| Q1 2021 | $466,000 | +4.0% | 17,806 | 0.0% | 0.28% | -17.9% |
| Q4 2020 | $448,000 | – | 17,806 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 826,488 | $23,918,563 | 3.20% |
| ARMISTICE CAPITAL, LLC | 4,650,000 | $134,571,000 | 1.84% |
| Seaport Global Advisors, LLC | 16,069 | $465,037 | 1.11% |
| Aristotle Capital Boston, LLC | 1,159,828 | $33,565,419 | 1.03% |
| S&T BANK/PA | 189,356 | $5,480 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 529,952 | $15,336,811 | 0.89% |
| Bridge City Capital, LLC | 78,675 | $2,276,855 | 0.88% |
| Tributary Capital Management, LLC | 346,261 | $10,020,793 | 0.84% |
| Bruce & Co., Inc. | 82,105 | $2,376,119 | 0.83% |
| Stephens Investment Management Group LLC | 1,904,864 | $55,126,764 | 0.81% |